Close Menu

NEW YORK — Fulgent Genetics said on Thursday that it has received a clinical laboratory permit and approval from the New York State Department of Health (NYSDOH) to offer its next-generation sequencing tests. 

Fulgent sells genetic tests for a range of diseases and disorders, as well as custom panels for over 18,000 genes. The Temple City, California-based company also offers sequencing services for clinical and research applications.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.